Google Alert - hepatitis c

[Guest guest]

News

6 new results for hepatitis c

Two-thirds of Hepatitis C Patients Can See a Cure in Half the Time, New Study ...HealthCanal.comLOS ANGELES – Treatment with a telaprevir-based combination regimen for hepatitis C – heretofore a chronic, destructive and difficult to manage disease – effectively can be shortened to six months in about two-thirds of patients, finds a new study ...See all stories on this topic »

Insurance firm told to pay hepatitis patient 1.6 lakhTimes of IndiaMUMBAI: Undergoing treatment for hepatitis C in 2006, which he contracted due to an infected blood transfusion in 1988, cost a Ghatkopar resident his health and Rs 1.58 lakh. To his relief, ruling in his favour, the Mumbai Suburban District Consumer ...See all stories on this topic »

Researchers Find Achilles' Heel Of Hepatitis C Virus, Boosts Hope For VaccineAsian Scientist MagazineBy Lim Efforts to create an effective vaccine against the potentially fatal Hepatitis C virus have received a major boost following the discovery of two weaknesses within the virus. AsianScientist (Sep. 19, 2011) – Efforts to create an ...See all stories on this topic »

Asian Scientist Magazine

Denied health insurance, Hepatitis patient gets relief from forumMumbai NewslineShah had contracted Hepatitis C in 2006 due to an infected blood transfusion during his treatment for ulcer and duodenal bleeding in 1988. He had to shell out Rs 1.58 lakh for treatment, but could not avail his medical insurance cover as the company ...See all stories on this topic »

Hepatitis infections in the UAE declineEmirates 24/7The UAE Health Department has reported a decline in the rates of infections by hepatitis ©. According to Dr. Mohammed Al Za'abi, consultative gastroenterology and liver transplantation this is due to medical advances and increasing health awareness ...See all stories on this topic »

7 Possible Biotech Takeover TargetsSeeking AlphaVertex has an FDA approved drug called Incivek for the treatment of hepatitis C. They also have four drugs in Phase 2 clinical testing for the treatment of: Cystic fibrosis, hepatitis C, immune-mediated inflammatory disease, and epilepsy. ...See all stories on this topic »